Concerning the MAPK/ERK signaling pathway, which is constitutively activated in pancreatic cancer cells, we have shown that pancreatic tumor tissues from patients >65 years old are associated with reduced ERK1 transcript levels than in healthy tissues within the same age range. This evidence concerns the gene MAPK3 and familial pancreatic carcinoma.